The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 05, 2024

Filed:

Nov. 13, 2018
Applicant:

The Johns Hopkins University, Baltimore, MD (US);

Inventors:

Kannan Rangaramanujam, Highland, MD (US);

Rishi Sharma, Baltimore, MD (US);

Anjali Sharma, Baltimore, MD (US);

Sujatha Kannan, Highland, MD (US);

Zhi Zhang, Towson, MD (US);

Siva Pramodh Kambhampati, Baltimore, MD (US);

Assignee:

THE JOHNS HOPKINS UNIVERSITY, Baltimore, MD (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 45/06 (2006.01); A61K 47/60 (2017.01); A61K 47/68 (2017.01); C08G 83/00 (2006.01); A61K 47/18 (2017.01);
U.S. Cl.
CPC ...
A61K 47/6885 (2017.08); A61K 9/0019 (2013.01); A61K 45/06 (2013.01); A61K 47/60 (2017.08); C08G 83/003 (2013.01); C08G 83/004 (2013.01); A61K 47/183 (2013.01);
Abstract

Low-generation dendrimers containing a high density of surface hydroxyl groups, and methods of synthesis thereof are provided. In particular, oligo ethylene glycol (OEG)-like dendrimers with a high surface functional groups at relatively low generations (e.g. ˜120 hydroxyls in the third generation, with a size of just 1-2 nm) is described. Dendrimer formulations including one or more prophylactic, therapeutic, and/or diagnostic agents, and methods of use thereof are also described. The formulations are suitable for topical, enteral, and/or parenteral delivery for treating one or more diseases, conditions, and injuries in the eye, the brain and nervous system (CNS), particularly those associated with pathological activation of microglia and astrocytes.


Find Patent Forward Citations

Loading…